Digital Ally Partners with Redwood Scientific to Launch Anti-Vaping Product TBX Vape-Free.

Digital Ally has signed an exclusive global distribution deal with Redwood Scientific Technologies for Redwood's nicotine cessation products, including TBX-Free and TBX Vape-Free. The products aim to help Americans overcome addiction to vape devices. Digital Ally will have exclusive rights to distribute Redwood's technologies, brands, and manufacturing processes globally. The deal could reshape how the US approaches nicotine addiction, pending successful clinical trials.

Title: Digital Ally Secures Exclusive Global Distribution Rights for Redwood Scientific's Nicotine Cessation Products

Digital Ally, Inc. (NASDAQ: DGLY) has signed an exclusive global Master Distribution Agreement with Redwood Scientific Technologies, granting the company exclusive rights to distribute Redwood's nicotine cessation products, including TBX-Free and TBX Vape-Free. The agreement aims to help Americans overcome addiction to vape devices and traditional cigarettes, addressing a significant health crisis in the United States.

TBX-Free is designed to assist cigarette smokers in overcoming nicotine addiction, while TBX Vape-Free is a pioneering oral thin-film solution specifically targeting vape-related nicotine dependency. The agreement grants Digital Ally exclusive rights to Redwood's technologies, brands, trademarks, and manufacturing processes. According to the CDC, approximately 28.8 million U.S. adults are current cigarette smokers, and 4.5% of adults aged 18 and over report current e-cigarette use [1].

The partnership represents a strategic pivot for Digital Ally into the healthcare technology space. The company plans to launch full-scale distribution following the completion of Redwood's final-stage clinical trial. No sales or marketing will begin until the clinical study concludes, making this a pre-revenue development for now. However, the potential market for these products is substantial, with the CDC reporting 4.5% of U.S. adults currently using e-cigarettes alongside 28.8 million cigarette smokers [2].

Digital Ally's exclusive distribution agreement with Redwood Scientific highlights the company's diversification strategy and could transform its revenue model and market positioning. The tobacco cessation market has historically offered high margins, and securing exclusive distribution rights to an innovative, first-of-its-kind product could create substantial value if clinical trials demonstrate efficacy. The timing aligns with increasing regulatory scrutiny on vaping products, potentially accelerating market adoption once available.

References:
[1] https://www.stocktitan.net/news/DGLY/digital-ally-signs-exclusive-master-distribution-deal-with-redwood-xe5iclw3haxd.html
[2] https://www.globenewswire.com/news-release/2025/06/23/3103399/10618/en/Digital-Ally-Signs-Exclusive-Master-Distribution-Deal-with-Redwood-Scientific-to-Launch-Breakthrough-Anti-Vaping-Product.html